Trial reportInternational urology and nephrology2026
Haemostatic effectiveness of intranasal desmopressin for tunnelled dialysis catheter placement: a pilot randomised controlled trial.
Trial report in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the effectiveness of intranasal desmopressin in reducing exit-site bleeding during the placement of tunnelled dialysis catheters.
methodsThis open-label randomised controlled trial was done on patients aged ≥ 12 years undergoing placement of tunnelled dialysis catheters. Exclusion criteria included current use of anticoagulants, platelet count < 50 × 10
resultsThere were 86 patients aged 56.41 ± 15.64 years. The majority of the catheters (79; 91.86%) were placed in the right internal jugular vein. In the intervention arm, six patients (13.95%) experienced bleeding from the catheter exit site, compared to eleven patients (25.58%) in the control arm (p = 0.176). Purse-string suturing was required for six (13.95%) patients in the intervention arm and ten (23.26%) patients in the control arm (p = 0.268). No patient reported significant side effects.
conclusionThere was a statistically insignificant reduction in exit-site bleeding with intranasal desmopressin. TRIAL REGISTRY: Iranian Clinical Trial Registry (IRCT20240215061017N2).
Indexed as
Identifiers
41863745What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.